Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2021-08-16

FDA Approved: ONDANSETRON — Supplemental Application (Hikma Pharmaceuticals USA Inc.)

View source ↗

Summary

FDA approved a supplemental application for ondansetron by Hikma Pharmaceuticals USA Inc., confirming the continued availability/approval of the generic product…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Ondansetron (ondansetron)

Snippet

SUPPL AP for ONDANSETRON (ONDANSETRON)